Skip to main content

Peer Review reports

From: Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial

Original Submission
3 Jun 2021 Submitted Original manuscript
17 Aug 2021 Reviewed Reviewer Report - Alexander Gough
24 Sep 2021 Reviewed Reviewer Report - Marlana Orloff
28 Oct 2021 Author responded Author comments - Thaïs M.L. Tong
Resubmission - Version 2
28 Oct 2021 Submitted Manuscript version 2
2 Nov 2021 Reviewed Reviewer Report - Alexander Gough
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
16 Jan 2022 Editorially accepted
13 Feb 2022 Article published 10.1186/s13063-022-06036-y

You can find further information about peer review here.

Back to article page